The Build Back Better Act contains a nicotine tax that negatively impacts tobacco harm reduction efforts and public health.
House Votes for Biden’s Build Back Broke Bill
The BBBA is a disastrous and wasteful bill that will raise costs further for all Americans and increase government control.
Build Back Better Act Will Destroy Vibrant U.S. Pharmaceutical Industry
CAGW’s latest report “Price Controls on Pharmaceuticals Are Bad Medicine,” analyzes destructive policies in the BBBA.
Three Reforms States Should Consider After the COVID-19 Pandemic
States should reform how they raise revenue, plan better for the future, and relax workforce regulations.
The Republic is Safe, For Now
Congress has been on recess for a week, so the nation is safe from more prolific spending – for now.
Congress Should Listen to Voters and Reject Drug Price Controls
A message was sent by voters in Virginia, New Jersey, and New York last night. Is Congress listening?
Price Controls Must Not Be Included in Reconciliation
The Biden administration and congressional leaders aim to implement price controls on healthcare.
Will Michigan’s State Legislators Micromanage PBMs?
Interfering in private contracts between pharmacy benefit managers and their customers will drive drug costs up, not down.
No Government Price Controls to Pay for Biden’s Gargantuan Spending Bill
Sen. Ron Wyden (D-Ore.) wants to use price controls in Medicare Part D to pay for President Biden’s extravagant spending.
Obamacare Survives Third Court Challenge
The Supreme Court tossed out ObamaCare lawsuit, California et al v. Texas, stating the plaintiffs have no standing.